OpportunityTitle: BJA FY 10 Harold Rogers Prescription Drug Monitoring Program
AdditionalInformationOnEligibility: Planning Grants: Applicants are limited to state* governments without enabling statutes or regulations.    Implementation and Enhancement Grants: Applicants are limited to state governments that have in place an enabling statute or regulation requiring the submission of controlled substance prescription data to an authorized state agency.    Within Category 3 in FY 2010, funding priority will be given to applicants who propose to implement information sharing with other state Prescription Drug Monitoring Programs (PDMPs) within the grant period using the prescription monitoring information exchange (PMIX) specifications.  PDMPs should include:  &#149;  The required electronic submission of data for prescriptions in Schedules II, III, IV, and/or V and other scheduled listed chemical products.  &#149;  The submission of data elements consistent with standards established by the American Society for Automation in Pharmacy.  &#149;  Access to collected data by federal, state, and local law enforcement and public health officials.  &#149;  Confidentiality and privacy provisions regarding the collected data.  &#149;  The authority and capability to exchange information with other state PDMPs.
Description: The primary purpose of the Harold Rogers Prescription Drug Monitoring Program (PDMP) is to enhance the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled listed chemical products through a centralized database administered by an authorized state agency. The program was created by the FY 2002 U.S. Department of Justice Appropriations Act (Public Law 107-77) and has received funding under each subsequent year&#146;s Appropriations Act.
GrantorContactEmailDescription: Technical Application Assistance
GrantorContactText: Al Roddy &lt;br/&gt;Technical Application Assistance &lt;br/&gt;202-353-1881